Skip to main content

Table 2 Correlation of PRDM1 and miR-223 expression with clinical factors and prognostic value

From: The downregulation of PRDM1/Blimp-1 is associated with aberrant expression of miR-223 in extranodal NK/T-cell lymphoma, nasal type

    PRDM1 expression     miR-223 expression  
  n Percent Negative Positive P n Percent Negative Positive P
Patients 61      31     
male 34 55.74 26 8 0.829 19 61.29 5 14 0.704
female 27 44.26 20 7   12 38.71 4 8  
Age (year) 61      31     
<40 29 47.54 21 8 0.463 13 41.94 4 9 NA
40-60 20 32.79 17 3   11 35.48 2 9  
>60 12 19.67 8 4   7 22.58 2 5  
Stage 46      26     
І/ІІ 18 39.13 9 9 0.009 9 34.62 3 6 0.661
III/IV 28 60.87 24 4   17 65.38 4 13  
Outcome 35      21     
alive 12 34.29 6 6 0.038 8 38.10 3 5 0.325
dead 23 65.71 20 3   13 61.90 2 11  
5-year OS 35      21     
Mean ± SD    39.49 ± 9.62 64.02 ± 11.48 0.045    53.40 ± 18.41 45.70 ± 10.05 0.504
OS 35      21     
Mean ± SD    44.72 ± 10.41 64.02 ± 11.48 0.084    53.40 ± 18.41 52.84 ± 10.70 0.784
FFS 35      21     
Mean ± SD    26.50 ± 5.60 57.41 ± 11.60 0.042    43.20 ± 16.89 38.99 ± 7.84 0.691
  1. NA, not analyzed, because of limited sample size.
  2. Ann Arbor Stage.